A Roth

816 total citations
27 papers, 616 citations indexed

About

A Roth is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, A Roth has authored 27 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 8 papers in Surgery. Recurrent topics in A Roth's work include Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (8 papers). A Roth is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (8 papers). A Roth collaborates with scholars based in Switzerland, Germany and Italy. A Roth's co-authors include Roger Stupp, J. Bernhard, Ralph A. Schmid, Anastase Spiliopoulos, Walter Mingrone, Hans Ris, Monika Jermann, Pierluigi Ballabeni, Walter Weder and Didier Lardinois and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Medicine and Annals of Oncology.

In The Last Decade

A Roth

27 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Roth Switzerland 9 356 236 128 102 89 27 616
Takeshi Inoue Japan 10 101 0.3× 45 0.2× 65 0.5× 102 1.0× 102 1.1× 34 398
Maria Fragoso Portugal 12 171 0.5× 328 1.4× 128 1.0× 108 1.1× 59 0.7× 19 507
P. J. Cagnoni United States 10 90 0.3× 151 0.6× 28 0.2× 56 0.5× 28 0.3× 16 312
S Matthes United States 10 97 0.3× 207 0.9× 66 0.5× 43 0.4× 57 0.6× 16 382
Katarzyna Bilska Poland 12 208 0.6× 58 0.2× 57 0.4× 76 0.7× 27 0.3× 37 347
R. Sauer Germany 9 119 0.3× 239 1.0× 75 0.6× 162 1.6× 71 0.8× 18 467
Daniela Capacchione Italy 7 89 0.3× 51 0.2× 224 1.8× 53 0.5× 191 2.1× 10 362
Setsuko Takeshita Japan 10 313 0.9× 277 1.2× 114 0.9× 43 0.4× 12 0.1× 14 632
Tomoki Ryu Japan 14 80 0.2× 104 0.4× 31 0.2× 157 1.5× 99 1.1× 53 525
Tao Zheng China 12 232 0.7× 140 0.6× 190 1.5× 127 1.2× 18 0.2× 42 501

Countries citing papers authored by A Roth

Since Specialization
Citations

This map shows the geographic impact of A Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Roth more than expected).

Fields of papers citing papers by A Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Roth. The network helps show where A Roth may publish in the future.

Co-authorship network of co-authors of A Roth

This figure shows the co-authorship network connecting the top 25 collaborators of A Roth. A scholar is included among the top collaborators of A Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Roth. A Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koessler, Thibaud, et al.. (2015). [Early oesophageal cancer: epidemiology diagnosis and management].. PubMed. 11(475). 1130–5. 1 indexed citations
2.
3.
Tejpar, Sabine, Vlad Popovici, Mauro Delorenzi, et al.. (2010). Mutant KRAS and BRAF gene expression profiles in colorectal cancer: Results of the translational study on the PETACC 3-EORTC 40993-SAKK 60-00 trial.. Journal of Clinical Oncology. 28(15_suppl). 3505–3505. 7 indexed citations
4.
Tejpar, Sabine, Fred T. Bosman, Mauro Delorenzi, et al.. (2009). Microsatellite instability (MSI) in stage II and III colon cancer treated with 5FU-LV or 5FU-LV and irinotecan (PETACC 3-EORTC 40993-SAKK 60/00 trial). Journal of Clinical Oncology. 27(15_suppl). 4001–4001. 68 indexed citations
5.
Bang, Yu Jeong, S. Yalçin, A Roth, et al.. (2009). Registry of gastric cancer treatment evaluation (REGATE): Baseline characteristics of 10,299 patients from 22 countries. Journal of Clinical Oncology. 27(15_suppl). 4575–4575. 5 indexed citations
6.
Weder, Walter, Rolf A. Stahel, J. Bernhard, et al.. (2007). Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Annals of Oncology. 18(7). 1196–1202. 239 indexed citations
7.
Roth, A, et al.. (2006). Pneumocystis jiroveci-Pneumonie bei immunsupprimierten Patienten ohne AIDS-Erkrankung - eine Fallserie. DMW - Deutsche Medizinische Wochenschrift. 131(27). 1515–1520. 3 indexed citations
8.
9.
Cutsem, Eric Van, Roberto Labianca, D Hossfeld, et al.. (2005). Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (pts). (PETACC 3). Journal of Clinical Oncology. 23(16_suppl). LBA8–LBA8. 93 indexed citations
10.
Roth, A, Rudolf Maibach, Nicola Fazio, et al.. (2004). 5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere®)–cisplatin in advanced gastric carcinoma: a phase I–II trial. Annals of Oncology. 15(5). 759–764. 36 indexed citations
11.
12.
Roth, A, Nicola Fazio, Olivia Pagani, et al.. (1999). 5FU as protracted continuous IV infusion (5FUpiv) can be added to full dose taxotere-cisplatin (TC) in advanced gastric carcinoma (AGC). European Journal of Cancer. 35. S139–S139. 8 indexed citations
13.
Roth, A, et al.. (1998). Colon Cancers and Peritoneal Mesothelioma Occurring 29 Years after Abdominal Radiation for Testicular Seminoma. Oncology. 55(4). 289–292. 10 indexed citations
14.
Roth, A, Giovanni Martinelli, Nicola Fazio, et al.. (1997). Taxotere-cisplatin (TC) in advanced gastric carcinoma (AGC): A promising drug combination. European Journal of Cancer. 33. S275–S276. 2 indexed citations
15.
Roth, A, et al.. (1997). Randomised clinical study (phase III) FE vs. FEP in advanced gastric cancer. European Journal of Cancer. 33. S275–S275. 2 indexed citations
16.
Roth, A, et al.. (1989). Cytostatic treatment of metastatic cervical carcinoma.. PubMed. 43(1). 65–75. 1 indexed citations
17.
Viard, Jean‐Paul, Philippe Lesavre, Christian Boîtard, et al.. (1988). POEMS syndrome presenting as systemic sclerosis. The American Journal of Medicine. 84(3). 524–528. 57 indexed citations
18.
Nagy, Balázs, et al.. (1988). Combined cis-Platinum plus Radiation Antitumor Activity in Locoregionally Advanced Squamous Cell Esophageal Cancer. Oncology. 45(4). 276–280. 7 indexed citations
19.
Kolarić, Krsto & A Roth. (1980). Treatment of metastatic brain tumors with the combination of 1-methyl-1-nitrosourea (MNU) and cyclophosphamide. Journal of Cancer Research and Clinical Oncology. 97(2). 193–198. 5 indexed citations
20.
Cg, Moertel, et al.. (1976). Who responds to sugar pills?. PubMed. 51(2). 96–100. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeshi Inoue Breakdown of academic impact, for papers by Maria Fragoso Breakdown of academic impact, for papers by P. J. Cagnoni Breakdown of academic impact, for papers by S Matthes Breakdown of academic impact, for papers by Katarzyna Bilska Breakdown of academic impact, for papers by R. Sauer Breakdown of academic impact, for papers by Daniela Capacchione Breakdown of academic impact, for papers by Setsuko Takeshita Breakdown of academic impact, for papers by Tomoki Ryu Breakdown of academic impact, for papers by Tao Zheng
Rankless by CCL
2026